Internal Medicine, Infectious Disease · La Jolla, CA
NPI
1942485883
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9898 Genesee Ave, Amp-605
La Jolla, CA, 92037
Phone (858) 824-5484
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,217 services
Medicare patients, 2024
297
Average age 75
Drug cost, 2024
$337K
391 prescriptions
Company payments, 2024
$24.78
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Preziosi was code 99233 (hospital e&m - subsequent), 164 times for 83 patients. In total Michael Preziosi billed 1,217 services in 18 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 164 | 83 | $96.10 | $16K |
| 99223 Hospital E&M - Initial | Facility | 146 | 140 | $139.53 | $20K |
| 99213 Office E&M - Established | Office | 90 | 75 | $72.39 | $6,515 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 70 | 14 | $4.49 | $315 |
| 99204 Office E&M - New | Office | 36 | 36 | $136.79 | $4,924 |
| 99214 Office E&M - Established | Office | 31 | 27 | $105.36 | $3,266 |
| 99203 Office E&M - New | Office | 28 | 28 | $92.01 | $2,576 |
| 96365 Intravenous Infusion, Hydration | Office | 17 | 15 | $39.51 | $672 |
| 99212 Office E&M - Established | Office | 11 | 11 | $48.67 | $535 |
By year: 2022 $62K for 1,677 services; 2023 $64K for 11,034 services; 2024 $57K for 1,217 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Preziosi prescribed most often to Medicare patients was Doxycycline Hyclate, with 43 prescriptions and refills. In total Michael Preziosi wrote 391 Medicare prescriptions that cost $337K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 43 | 73 | 18 | $1,347 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 36 | 46 | Under 11 | $172K |
| Penicillin V Potassium Generic | 31 | 72 | 11 | $237 |
| Amoxicillin Generic | 19 | 40 | Under 11 | $228 |
| Valacyclovir Valacyclovir Hcl | 16 | 26 | Under 11 | $331 |
| Amikacin Sulfate Generic | 14 | 14 | Under 11 | $2,620 |
| Dicloxacillin Sodium Generic | 13 | 19 | Under 11 | $1,944 |
| Juluca Dolutegravir/Rilpivirine | 13 | 13 | Under 11 | $47K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 13 | 22 | Under 11 | $76.04 |
| Ritonavir Generic | 12 | 14 | Under 11 | $751 |
| Rifampin Generic | 12 | 12 | Under 11 | $425 |
| Dovato Dolutegravir Sodium/Lamivudine | 11 | 11 | Under 11 | $30K |
Brand drugs: 89 claims; generic drugs: 302 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Michael Preziosi $24.78 ($24.78 in general payments such as food, travel and fees) from 1 company. The largest payer was ViiV Healthcare Company with $24.78.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 1 | $24.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.